Market Cap (In KRW)
423.95 Billion
Revenue (In KRW)
65.04 Billion
Net Income (In KRW)
25.58 Billion
Avg. Volume
999.8 Thousand
- Currency
- KRW
- Country
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 4250.0-8000.0
- PE
- -
- EPS
- -
- Beta Value
- 0.647
- ISIN
- KR7099430001
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Industry
- CEO
- Hyun-Kyu Jung
- Employee Count
- -
- Website
- https://www.ubioplus.co.kr
- Ipo Date
- 2021-09-27
- Details
- Bio Plus Co., Ltd engages in the research and development, production, and sale of bio products in South Korea. It offers dermal fillers under the SkinPlus Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses brand names. The company also provides medical products, including InterBlock, an absorbable anti-adhesion barrier; Synofil, a synovial fluid replacement; and Blad-Care, a solution to temporarily improve cystitis symptoms. In addition, it offers mesotherapy products, such as skin rejuvenation products under the Kiara Reju name; Slim Slimmer, a lipolysis solution; LumiDew, a whitening solution; JuveniHill, an anti-wrinkle solution; and hair scalp care, hair treatment, hair nutrition solutions under the BelloHa and BellaChe names, as well as cosmetics comprising heparinoid essence, EGF ball, and skin care gel under the La Bella name. The company was founded in 2003 and is based in Seongnam-si, South Korea.
More Stocks
-
9072
-
OM
-
ZPHYFZephyr Minerals Ltd.
ZPHYF
-
SUTLEJTEXSutlej Textiles and Industries Limited
SUTLEJTEX
-
2894Ishii Food Co., Ltd.
2894
-
BNAIW
-
EBRGF
-
AHR